Literature DB >> 10822387

Caspases and mitochondria in c-Myc-induced apoptosis: identification of ATM as a new target of caspases.

A Hotti1, K Järvinen, P Siivola, E Hölttä.   

Abstract

The mechanism(s) of c-Myc transcription factor-induced apoptosis is still obscure. The activation of c-Myc has been found to lead into the processing/activation of caspases (caspase-3), but the significance of this for the cell demise is debatable. Here we report that several targets of caspases (PKCdelta, MDM2, PARP, replication factor C, 70 kDa U1snRNP, fodrin and lamins) are cleaved during c-Myc-induced apoptosis in Rat-1 MycER cells, indicating an important role for caspases in the apoptotic process. We further found that the ATM (ataxia telangiectasia mutated)--protein is a novel key substrate of caspases. In in vitro assays, purified recombinant ATM protein was found to be cleaved by the effector caspases 3 and 7. The functional significance of the ATM cleavage is supported by the finding that ectopic expression of ATM protected in part against apoptosis. We also show that c-Myc-induced apoptosis involves loss of mitochondrial transmembrane potential, release of cytochrome c from mitochondria into the cytosol and subsequent processing of caspase-9. The cleavage of caspase-9 is, however, minimal and a much later event than the processing/activation of caspase-3, suggesting that it is not the apical caspase. Evidence is provided that there is, nevertheless, an upstream caspase(s) regulating the functions of caspase-3 and mitochondria. Additionally, it was found that p53 becomes upregulated, together with its transcriptional targets MDM2 and p21, upon c-Myc induction, but this occurs also at a later time than the activation of caspase-3.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10822387     DOI: 10.1038/sj.onc.1203567

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  17 in total

1.  Underexpression and abnormal localization of ATM products in ataxia telangiectasia patients bearing ATM missense mutations.

Authors:  Virginie Jacquemin; Guillaume Rieunier; Sandrine Jacob; Dorine Bellanger; Catherine Dubois d'Enghien; Anthony Laugé; Dominique Stoppa-Lyonnet; Marc-Henri Stern
Journal:  Eur J Hum Genet       Date:  2011-11-09       Impact factor: 4.246

2.  Linking sister chromatid cohesion and apoptosis: role of Rad21.

Authors:  Debananda Pati; Nenggang Zhang; Sharon E Plon
Journal:  Mol Cell Biol       Date:  2002-12       Impact factor: 4.272

3.  Expression profiling and interferon-beta regulation of liver metastases in colorectal cancer cells.

Authors:  Regis Zimmer; Peter Thomas
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

4.  Novel mutations and defective protein kinase C activation of T-lymphocytes in ataxia telangiectasia.

Authors:  M A García-Pérez; L M Allende; A Corell; P Varela; A A Moreno; A Sotoca; A Moreno; E Paz-Artal; E Barreiro; A Arnaiz-Villena
Journal:  Clin Exp Immunol       Date:  2001-03       Impact factor: 4.330

5.  Discovery of putative oocyte quality markers by comparative ExacTag proteomics.

Authors:  Michael D Powell; Gaurishankar Manandhar; Lee Spate; Miriam Sutovsky; Shawn Zimmerman; Shrikesh C Sachdev; Mark Hannink; Randall S Prather; Peter Sutovsky
Journal:  Proteomics Clin Appl       Date:  2010-01-04       Impact factor: 3.494

6.  The c-Myc target gene PRDX3 is required for mitochondrial homeostasis and neoplastic transformation.

Authors:  Diane R Wonsey; Karen I Zeller; Chi V Dang
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-14       Impact factor: 11.205

7.  Myc down-regulation affects cyclin D1/cdk4 activity and induces apoptosis via Smac/Diablo pathway in an astrocytoma cell line.

Authors:  D Amendola; M De Salvo; R Marchese; C Verga Falzacappa; A Stigliano; E Carico; E Brunetti; M Moscarini; B Bucci
Journal:  Cell Prolif       Date:  2009-02       Impact factor: 6.831

8.  Immunodeficiency in ataxia telangiectasia is correlated strongly with the presence of two null mutations in the ataxia telangiectasia mutated gene.

Authors:  E R Staples; E M McDermott; A Reiman; P J Byrd; S Ritchie; A M R Taylor; E G Davies
Journal:  Clin Exp Immunol       Date:  2008-05-26       Impact factor: 4.330

Review 9.  ATM and ATR: sensing DNA damage.

Authors:  Jun Yang; Zheng-Ping Xu; Yun Huang; Hope E Hamrick; Penelope J Duerksen-Hughes; Ying-Nian Yu
Journal:  World J Gastroenterol       Date:  2004-01-15       Impact factor: 5.742

10.  Granzyme B Induces IRF-3 Phosphorylation through a Perforin-Independent Proteolysis-Dependent Signaling Cascade without Inducing Cell Death.

Authors:  Eric J Gapud; Maria Isabel Trejo-Zambrano; Eduardo Gomez-Banuelos; Eleni Tiniakou; Brendan Antiochos; David J Granville; Felipe Andrade; Livia Casciola-Rosen; Antony Rosen
Journal:  J Immunol       Date:  2020-12-07       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.